Anti-S47A1/ SLC47A1/ MATE1 monoclonal antibody

Anti-S47A1/ SLC47A1/ MATE1 antibody for FACS & in-vivo assay

Target products collectionGo to SLC47A1/SLC47A1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T39676-Ab-1/ GM-Tg-hg-T39676-Ab-2Anti-Human SLC47A1 monoclonal antibodyHuman
GM-Tg-rg-T39676-Ab-1/ GM-Tg-rg-T39676-Ab-2Anti-Rat SLC47A1 monoclonal antibodyRat
GM-Tg-mg-T39676-Ab-1/ GM-Tg-mg-T39676-Ab-2Anti-Mouse SLC47A1 monoclonal antibodyMouse
GM-Tg-cynog-T39676-Ab-1/ GM-Tg-cynog-T39676-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC47A1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T39676-Ab-1/ GM-Tg-felg-T39676-Ab-2Anti-Feline SLC47A1 monoclonal antibodyFeline
GM-Tg-cang-T39676-Ab-1/ GM-Tg-cang-T39676-Ab-2Anti-Canine SLC47A1 monoclonal antibodyCanine
GM-Tg-bovg-T39676-Ab-1/ GM-Tg-bovg-T39676-Ab-2Anti-Bovine SLC47A1 monoclonal antibodyBovine
GM-Tg-equg-T39676-Ab-1/ GM-Tg-equg-T39676-Ab-2Anti-Equine SLC47A1 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T39676-Ab-1/ GM-Tg-hg-T39676-Ab-2; GM-Tg-rg-T39676-Ab-1/ GM-Tg-rg-T39676-Ab-2;
GM-Tg-mg-T39676-Ab-1/ GM-Tg-mg-T39676-Ab-2; GM-Tg-cynog-T39676-Ab-1/ GM-Tg-cynog-T39676-Ab-2;
GM-Tg-felg-T39676-Ab-1/ GM-Tg-felg-T39676-Ab-2; GM-Tg-cang-T39676-Ab-1/ GM-Tg-cang-T39676-Ab-2;
GM-Tg-bovg-T39676-Ab-1/ GM-Tg-bovg-T39676-Ab-2; GM-Tg-equg-T39676-Ab-1/ GM-Tg-equg-T39676-Ab-2
Products NameAnti-SLC47A1 monoclonal antibody
Formatmab
Target NameSLC47A1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SLC47A1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species S47A1/ SLC47A1/ MATE1 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP002190human SLC47A1 Lentivirus particle
    ORF Viral VectorpGMLP002190human SLC47A1 Lentivirus plasmid
    ORF Viral VectorpGMLPm004346mouse Slc47a1 Lentivirus plasmid
    ORF Viral VectorvGMLPm004346mouse Slc47a1 Lentivirus particle


    Target information

    Target IDGM-T39676
    Target NameSLC47A1
    Gene ID55244,703544,616474
    Gene Symbol and SynonymsMATE1,SLC47A1
    Uniprot AccessionQ96FL8
    Uniprot Entry NameS47A1_HUMAN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000142494
    Target ClassificationN/A

    The target: SLC47A1, gene name: SLC47A1, also named as MATE1. This gene is located within the Smith-Magenis syndrome region on chromosome 17. It encodes a protein of unknown function. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.